What's new? Log in Free sign up

Celyad Oncology (CLYYF)

Company Profile

Company profile

Ticker

CLYYF

Exchange

Website

www.celyad.com/

CEO

Filippo Petti

Incorporated

Location

Fiscal year end

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Alabama Power • Mississippi Power • Teva Pharmaceutical Industries Limited • Entergy Arkansas • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb ...

Former names

CARDIO3 BIOSCIENCES S.A., CELYAD S.A.

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

CLYYF stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Securities registration termination (foreign)

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Publication of a transparency notification received from Fortress Investment Group LLC

Current report (foreign)

Celyad announces management change

Current report (foreign)

Celyad Oncology reports third quarter 2023 financial

Publication of a transparency notification received from

Current report (foreign)

Information on the Total Number of Voting Rights and Total Number of shares with single voting rights

Transcripts

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

Fortress Investment Group LLC

Fortress Investment Group LLC

Fortress Investment Group LLC

VICTORY CAPITAL MANAGEMENT INC

Beneficial ownership report (amended)

Financial summary

Financial statements Chart CLYYF financial data

Quarter (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2023

CLYYF institutional ownership history Ownership history

0.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1	3	-66.7%
Opened positions	1	0	NEW
Closed positions	3	5	-40.0%
Increased positions	0	0
Reduced positions	0	1	EXIT

13F shares	Current	Prev Q	Change
Total value	3.60 mm	5.68 mm	-36.6%
Total shares	9.00 k	6.09 k	+47.7%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Rhumbline Advisers	9.00 k	$3.60 mm	NEW

Largest transactions	Shares	Bought/sold	Change
Rhumbline Advisers	9.00 k	+9.00 k	NEW
NA.R National Bank of Canada	0.00	-3.40 k	EXIT
UBS UBS	0.00	-2.12 k	EXIT
WFC Wells Fargo & Company	0.00	-570.00	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.